QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates (CER) ...

Forensic science degree leads Texas A&M College of Agriculture and Life Sciences student toward law, policy and a broader ...

A new review in the International Journal of Legal Medicine examines how single-cell isolation techniques—from laser capture ...

Ever wondered how to lift a fingerprint? How to build a DNA profile from a single strand of hair? How to analyze blood ...

“Forensic Files” is headed back to the lab. Radial Entertainment has teamed with Content Partners and ITV America to produce ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) will bring together tuberculosis experts from around the world for the Global TB Clinical and Educational Summit from October 13-16 as a ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new artificial intelligence (AI) capabilities to help ...

In a study published Monday in Nature Communications, researchers developed an AI system that uses microbes on cadavers to estimate their postmortem intervals (PMI), or time since ...

An American tech CEO allegedly helped Russian nationals hide their ownership of a digital forensics company so it could land lucrative US government contracts — including a deal with the Secret ...

A former analyst for the Colorado Bureau of Investigation was sentenced to a decade in prison after pleading guilty to four ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the commercial launch of QIAsymphony Connect, an IVD-compliant platform for automated clinical nucleic acid extraction.

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx BCID GPF Plus AMR Panel, the first QIAstat-Dx panel for ...